Merck & Co Inc

XSGO : MRK

$128.40+0.00%

Financials

Income statement · full history

USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.

Reported line item	Dec 31, 201712 months	Dec 31, 201812 months	Dec 31, 201912 months	Dec 31, 202012 months	Dec 31, 202112 months	Dec 31, 202212 months	Dec 31, 202312 months	Dec 31, 202412 months	Dec 31, 202512 months

Income statement, full reported history for 0000310158. USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.
Reported line item	Jan 1, 2017 to Dec 31, 2017	Jan 1, 2018 to Dec 31, 2018	Jan 1, 2019 to Dec 31, 2019	Jan 1, 2020 to Dec 31, 2020	Jan 1, 2021 to Dec 31, 2021	Jan 1, 2022 to Dec 31, 2022	Jan 1, 2023 to Dec 31, 2023	Jan 1, 2024 to Dec 31, 2024	Jan 1, 2025 to Dec 31, 2025
Sales	40,122	42,294	39,121R	41,518R	48,704	59,283	60,115	64,168	65,011
Cost of sales	12,912	13,509	12,016R	13,618R	13,626	17,411	16,126	15,193	16,382
Selling, general and administrative	10,074R	10,102	9,455R	8,955R	9,634	10,042	10,504	10,816	10,733
Research and development	10,339R	9,752	9,724R	13,397R	12,245	13,548	30,531	17,938	15,789
Restructuring costs	776	632	626R	575R	661	337	599	309	889
Other (income) expense, net	(500)R	(402)	129R	(890)R	(1,341)	1,501	466	(24)	151
Total costs, expenses and other	33,601	33,593	31,950R	35,655R	34,825	42,839	58,226	44,232	43,944
Income Before Taxes	6,521	8,701	7,171R	5,863R	13,879	16,444	1,889	19,936	21,067
Taxes on Income	4,103	2,508	1,565R	1,340R	1,521	1,918	1,512	2,803	2,804
Net Income	2,418	6,193	5,606R	4,523R	12,358	14,526	377	17,133	18,263
Less: Net Income Attributable to Noncontrolling Interests			(84)	4	13	7	12	16	9
Less: Net Income (Loss) Attributable to Noncontrolling Interestsno longer reported	24	(27)	(66)	15
Net Income Attributable to Merck & Co., Inc.	2,394	6,220	9,843	7,067	13,049	14,519	365	17,117	18,254
Net Income from Continuing Operations Attributable to Merck & Co., Inc.no longer reported			5,690	4,519	12,345	14,519	365
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	0.88	2.34	3.84	2.79	5.16	5.73	0.14	6.76	7.30
Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interestsno longer reported			4,153	2,548	704	0	0
Income from Continuing Operations (in dollars per share)no longer reported			2.22	1.79	4.88	5.73	0.14
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	0.87	2.32	3.81	2.78	5.14	5.71	0.14	6.74	7.28
Income from Discontinued Operations (in dollars per share)no longer reported			1.62	1.01	0.28	0.00	0.00
Income from Continuing Operations (in dollars per share)no longer reported			2.21	1.78	4.86	5.71	0.14
Income from Discontinued Operations (in dollars per share)no longer reported					0.28	0.00	0.00
Income from Discontinued Operations (in dollars per share)no longer reported			1.61	1.00	0.28	0.00

History starts FY2017, the period ended Dec 31, 2017 — the earliest period our structured-data source covers, not the company’s first year.

22 reported lines · 9 periods · values taken from the latest filing that prints each period.

R23 restated by the filer — hover for the figure as first reported.
italic16 from an earlier filing than the rest of the column.
no longer reported8 lines the filer stopped printing.
— the filer printed the line and left the period empty. An empty cell means the line was not printed at all; it is never a zero.

160 of 160 values link to the exact element in the filer’s own document.

Every line and every caption is the company’s own. Each period carries the value from the latest filing that prints it, which is why a restated period shows the restated number with the figure as first reported kept underneath.

Nothing on this table is computed by us: no fourth quarter, no growth rate, no margin. Marks describe the filer’s own restatements.